Moderna, Inc.

The current price of MRNA is 102.00 USD — it has decreased by 1.39% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Moderna, Inc. stocks are traded under the ticker MRNA.

Moderna, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

MRNA stock is 3.61% volatile and has beta coefficient of 1.68. Check out the list of the most volatile stocks — is Moderna, Inc. there?

One year price forecast for Moderna, Inc. has a max estimate of 310.00 USD and a min estimate of 59.00 USD.

MRNA earnings for the last quarter are −9.53 USD whereas the estimation was −1.93 USD which accounts for −393.19% surprise. Estimated earnings for the next quarter are −0.99 USD. See more details about Moderna, Inc. earnings.

Moderna, Inc. revenue for the last quarter amounts to ‪1.83 B‬ USD despite the estimated figure of ‪1.38 B‬ USD. In the next quarter revenue is expected to reach ‪2.51 B‬ USD.

Yes, you can track Moderna, Inc. financials in yearly and quarterly reports right on TradingView.

MRNA net income for the last quarter is ‪217.00 M‬ USD, while the quarter before that showed ‪−3.63 B‬ USD of net income which accounts for 105.98% change. Track more Moderna, Inc. financial stats to get the full picture.

Today Moderna, Inc. has the market capitalization of ‪39.61 B‬, it has increased by 1.43% over the last week.

No, MRNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, MRNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moderna, Inc. stock right from TradingView charts — choose your broker and connect to your account.

MRNA reached its all-time high on Aug 10, 2021 with the price of 497.49 USD, and its all-time low was 11.54 USD and was reached on Aug 7, 2019.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has ‪5.60 K‬ employees. See our rating of the largest employees — is Moderna, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Moderna, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Moderna, Inc. stock shows the sell signal. See more of Moderna, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Moderna, Inc. future price: according to them, MRNA price has a max estimate of 310.00 USD and a min estimate of 59.00 USD. Read a more detailed Moderna, Inc. forecast: see what analysts think of Moderna, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Moderna, Inc. EBITDA is ‪−3.62 B‬ USD, and current EBITDA margin is −53.01%. See more stats in Moderna, Inc. financial statements.